Key statistics
On Monday, Altamira Therapeutics Ltd (CYTOF:PKC) closed at 0.10, 99.60% above the 52 week low of 0.0501 set on Sep 18, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.125 |
|---|---|
| High | 0.125 |
| Low | 0.10 |
| Bid | -- |
| Offer | -- |
| Previous close | 0.10 |
| Average volume | 8.94k |
|---|---|
| Shares outstanding | 5.72m |
| Free float | 4.64m |
| P/E (TTM) | -- |
| Market cap | 571.55k USD |
| EPS (TTM) | -1.45 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 17:57 GMT.
More ▼
- Altamira Therapeutics Announces Collaboration on Circular RNA Delivery
- Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results
- Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025
- Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent
